𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Promoter −202 A/C polymorphism of insulin-like growth factor binding protein-3 gene and non-small cell lung cancer risk

✍ Scribed by Jin Wook Moon; Yoon Soo Chang; Chul Woo Ahn; Kyeong Nam Yoo; Ju Hye Shin; Jee Hyun Kong; Young Sam Kim; Joon Chang; Sung Kyu Kim; Hee Jung Kim; Se Kyu Kim

Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
93 KB
Volume
118
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Insulin-like growth factor binding protein-3 (IGFBP-3) inhibits the mitogenic and antiapoptotic activity of insulin-like growth factor (IGF) by blocking the binding of IGF to its receptor. However, under certain circumstances, IGFBP-3 can enhance the activity of IGF by protecting IGF from degradation. More than half of the interindividual variations in IGFBP-3 levels are known to be genetically determined by the polymorphism at -202 locus of IGFBP-3 gene. Therefore, we attempted to ascertain whether the A-202C polymorphic variation of IGFBP-3 gene constitutes a risk factor for non-small cell lung cancer (NSCLC). Our study included 209 NSCLC patients and 209 age-, gender- and smoking status-matched control subjects. The frequencies of each polymorphic variation in the control population were as follows: AA = 95 (45.5%), AC = 91 (43.5%) and CC = 23 (11.0%). In the NSCLC subjects, the genotypic frequencies were as follows: AA = 131 (62.7%), AC = 73 (34.9%) and CC = 5 (2.4%). We detected statistically significant differences in the genotypic distribution between the NSCLC and the control subjects (p < 0.05, Pearson's chi-square test). The NSCLC risk correlated significantly with AA genotype. Using CC genotype as a reference, the odds ratio for the subjects with AC genotype was 2.45 (95% CI = 1.17-5.40) and that for the ones with AA genotype was 4.58 (95% CI = 2.17-10.30). These results indicate that the dysregulation of IGF axis should now be considered as another important risk factor for NSCLC and a potential target for novel antineoplastic therapies and/or preventative strategies in high-risk groups.

📜 SIMILAR VOLUMES

A prospective study of insulin-like grow
A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women
✍ Annekatrin Lukanova; Paolo Toniolo; Arslan Akhmedkhanov; Carine Biessy; Nancy J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 59 KB 👁 1 views

Insulin-like growth factor-I (IGF-I) has mitogenic and anti-apoptotic properties and has been implicated in the development of breast, colorectum, prostate and lung cancer. IGF binding proteins (IGFBPs) are not only carrier proteins for IGFs but also hold a central position in IGF ligand-receptor in

Circulating levels of insulin-like growt
Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer
✍ Lital Keinan-Boker; H. Bas Bueno de Mesquita; Rudolf Kaaks; Carla H. van Gils; P 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 85 KB 👁 1 views

## Abstract Higher levels of circulating Insulin‐like Growth Factor (IGF)‐I may be associated with higher risks for premenopausal breast cancer. We investigate the associations between circulating levels of IGF‐I, its binding proteins (IGFBPs) ‐1, ‐2, ‐3, C‐peptide and postmenopausal breast cancer.

Insulin-like growth factor (IGF)-I and I
Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: A meta-analysis of literature
✍ Aravind Sugumar; Yen-Chun Liu; Qiang Xia; Yea-Suk Koh; Keitaro Matsuo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 96 KB 👁 1 views

## Abstract Biologic evidence suggests substantial effect of insulin‐like growth factor (IGF)‐I in mammary cell carcinogenesis. However, controversy remains regarding the association between circulating IGF‐I levels and the risk of premenopausal breast cancer in epidemiologic studies. In addition,

Plasma C-peptide, insulin-like growth fa
Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: The Japan public health center-based prospective study
✍ Tetsuya Otani; Motoki Iwasaki; Shizuka Sasazuki; Manami Inoue; Shoichiro Tsugane 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB 👁 1 views

## Abstract The physical inactivity and obesity involved in hyperglycemia and hyperinsulinemia is supposed to lead to an increased bioavailability of insulin‐like growth factor‐I (IGF‐I). The carcinogenic effect of IGF‐I may be influenced by IGF binding proteins. We investigated the association bet